AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Australasian Biotechnology)
Bristol-Myers Squibb and Regeneron Pharmaceuticals Inc each have formed licensing agreements with GE Healthcare for rights to Aequorea Victoria Green Fluorescent Protein (AvGFP). The agreement will allow Bristol-Myers Squibb to use GFP in conducting primary and secondary screening, ...